Preface
1. Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins; Farid Rahimi and Gal Bitan
2. Pathologic Lesions in Alzheimer disease and Other Neurodegenerative Diseases-Cellular and Molecular Components; Harry V. Vinters, Spencer Tung, and Orestes E. Solis
3. Preparation and Structural Characterization of Pre-fibrillar Assemblies of Amyloidogenic Proteins; Anat Frydman-Marom, Yaron Bram, and Ehud Gazit
4. Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies; Kyle C. Wilcox, Jason Pitt, Adriano Sebollela, Helen Martirosova, Pascale N. Lacor, and William L. Klein
5. The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer's disease; Kiran Bhaskar and Bruce T. Lamb
6. Oligomers of α-Synuclein in the Pathogenesis of Parkinson's Disease; Dong-Pyo Hong, Wenbo Zhou, Aaron Santner3, and Vladimir N. Uversky
7. Cytotoxic Mechanisms of Islet Amyloid Polypeptide in the Pathogenesis of Type-2 Diabetes Mellitus (T2DM); Theri L. Degaki, Dahabada H. J. Lopes, and Mari C. Sogayar
8. Protein Misfolding and Toxicity in Amyotrophic Lateral Sclerosis; Aaron Kerman and Avijit Chakrabartty
9. Structural Studies of Prion Proteins and Prions; Giuseppe Legname, Gabriele Giachin, Federico Benetti
10. Role of Prion Protein Oligomers in the Pathogenesis of Transmissible Spongiform Encephalopathies; Rodrigo Morales, Claudia A. Duran-Aniotz, and Claudio Soto
11. When More Is Not Better: Expanded Polyglutamine Domains in Neurodegenerative Disease; Regina M. Murphy, Robert H. Walters, Matthew D. Tobelmann, and Joseph P. Bernacki
12. Protein Misfolding and Toxicity in Dialysis-Related Amyloidosis; John P. Hodkinson, Alison E. Ashcroft, Sheena E. Radford
13. Transthyretin Aggregation and Toxicity; Maria J. Saraiva, Isabel S. Cardoso
14. Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases; Jennifer D. Lanning and Stephen C. Meredith
